16 septembre 2014
Ce document est lié à :
http://archipel.uqam.ca/8520/
Ce document est lié à :
http://dx.doi.org/10.1038/ncomms5871
Ce document est lié à :
doi:10.1038/ncomms5871
Nicholas J. Timpson et al., « A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans », UQAM Archipel : articles scientifiques, ID : 10670/1.do3phd
The analysis of rich catalogues of genetic variation from population-based sequencing provides an opportunity to screen for functional effects. Here we report a rare variant in APOC3 (rs138326449-A, minor allele frequency ~0.25% (UK)) associated with plasma triglyceride (TG) levels (−1.43 s.d. (s.e.=0.27 per minor allele (P-value=8.0 × 10−8)) discovered in 3,202 individuals with low read-depth, whole-genome sequence. We replicate this in 12,831 participants from five additional samples of Northern and Southern European origin (−1.0 s.d. (s.e.=0.173), P-value=7.32 × 10−9). This is consistent with an effect between 0.5 and 1.5 mmol l−1 dependent on population. We show that a single predicted splice donor variant is responsible for association signals and is independent of known common variants. Analyses suggest an independent relationship between rs138326449 and high-density lipoprotein (HDL) levels. This represents one of the first examples of a rare, large effect variant identified from whole-genome sequencing at a population scale.